Hot off the Forge
-
Timothy J. Miller, Ph.D., CEO, President, and Co-Founder of Forge Biologics, and David Dismuke, Ph.D., Chief Technical Officer, will be…
-
Forge’s leadership team will be participating at upcoming investor conferences, including Cowen’s and Oppenheimer’s.
-
Partnership will help advance Ray Therapeutics’ lead optogenetics gene therapy program, Ray-001, into clinical trials for patients with retinitis pigmentosa.
-
“We are excited to deliver on our goal of offering our clients expanded manufacturing capacity, while providing access to some…
-
Timothy J. Miller, Ph.D., CEO, President, and Co-Founder, will be presenting.
-
The Forge leadership team, including CEO Dr. Timothy Miller; John Maslowski, Chief Commercial Officer; Christina Perry, Vice President of Finance…
-
Forge CEO Dr. Timothy J. Miller will also join a panel of gene therapy experts for a discussion on “Dosing…
-
Strategic alliance will help advance the development and manufacturing of SGT-003, Solid’s next generation gene therapy program for Duchenne.
-
“We are thankful to have a positive dialogue with the EMA and for gaining alignment with the FDA on the…
-
Juan Ruiz, M.D., Ph.D., M.B.A., joins as Senior Vice President of Medical Affairs, and Frank Agbogbo, Ph.D., M.B.A., joins as…
-
The strategic development and manufacturing partnership will help advance GentiBio’s unique immune tolerance platform.
-
“Forge Forward” aims to train and attract top talent with specialized Good Manufacturing Practice (GMP) training to the company.